Skip to main content
. 2010 Jul 8;12(9):678–686. doi: 10.1111/j.1751-7176.2010.00341.x

Figure 2.

Figure 2

 Model‐adjusted changes in blood pressure (mm Hg) measured by ambulatory blood pressure monitoring (efficacy population, last‐observation‐carried‐forward) comparing high‐dose monotherapy groups with the combined group who received either extended‐release carvedilol/lisonopril (Carv CR/Lis) 80/10 mg, 80/20 mg, 80/40 mg, 20/40 mg, and 40/40 mg. C indicates carvedilol; L, lisinopril; NS, not significant.